Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chim C Lang

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
Cardiovascular Therapeutics|June 26, 2015
Management of Noncardiac Comorbidities in Chronic Heart FailureVun Heng Chong, Jagdeep Singh, Helen Parry, et al.
Current Cardiology Reports|May 4, 2023
Correction to: Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: A Practical GuideJaved Khan, Fraser J Graham, Gabriele Masini, et al.
Journal of the American College of Cardiology|August 13, 2011
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectorisNarasimharajapura S Rajendra, Sheila Ireland, Jacob George, et al.
Heart (British Cardiac Society)|July 10, 2017
Sacubitril/valsartan: beyond natriuretic peptidesJagdeep S S Singh, Louise M Burrell, Myriam Cherif, et al.
International Journal of Cardiology|March 31, 2012
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trialMiles D Witham, Fiona J Dove, Faisel Khan, et al.
Pharmacogenomics|November 12, 2015
The future of pharmacogenetics in the treatment of heart failureMohamed Subhan Anwar, Muhammad Zaid Iskandar, Helen M Parry, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humansRahmatina B Herman, Peter J Jesudason, Ali M Mustafa, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failureKok H Chee, Kadirvelu Amudha, Nik A Hussain, et al.
ESC Heart Failure|April 3, 2020
Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetesIfy R Mordi, Aaron Tee, Colin N Palmer, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
Cardiovascular Therapeutics|June 26, 2015
Management of Noncardiac Comorbidities in Chronic Heart FailureVun Heng Chong, Jagdeep Singh, Helen Parry, et al.
Current Cardiology Reports|May 4, 2023
Correction to: Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: A Practical GuideJaved Khan, Fraser J Graham, Gabriele Masini, et al.
Journal of the American College of Cardiology|August 13, 2011
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectorisNarasimharajapura S Rajendra, Sheila Ireland, Jacob George, et al.
Heart (British Cardiac Society)|July 10, 2017
Sacubitril/valsartan: beyond natriuretic peptidesJagdeep S S Singh, Louise M Burrell, Myriam Cherif, et al.
International Journal of Cardiology|March 31, 2012
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trialMiles D Witham, Fiona J Dove, Faisel Khan, et al.
Pharmacogenomics|November 12, 2015
The future of pharmacogenetics in the treatment of heart failureMohamed Subhan Anwar, Muhammad Zaid Iskandar, Helen M Parry, et al.
British Journal of Clinical Pharmacology|February 13, 2003
Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humansRahmatina B Herman, Peter J Jesudason, Ali M Mustafa, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failureKok H Chee, Kadirvelu Amudha, Nik A Hussain, et al.
ESC Heart Failure|April 3, 2020
Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetesIfy R Mordi, Aaron Tee, Colin N Palmer, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Pageof 27